148 related items for PubMed ID: 38267591
1. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome.
Inoki Y, Nishi K, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Kamei K.
Pediatr Nephrol; 2024 Aug; 39(8):2393-2401. PubMed ID: 38267591
[Abstract] [Full Text] [Related]
2. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
3. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May 01; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
4. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
5. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N, Kim S, Craig J, Hodson E.
Arch Dis Child; 2016 Apr 01; 101(4):404-8. PubMed ID: 26289063
[Abstract] [Full Text] [Related]
6. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
[Abstract] [Full Text] [Related]
7. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.
Pediatr Nephrol; 2013 Feb 04; 28(2):257-64. PubMed ID: 23052656
[Abstract] [Full Text] [Related]
8. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar 04; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
9. Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome.
Lee H, Wang L, Ni FF, Yang XY, Feng SP, Gao XJ, Chi H, Luo YT, Chen XL, Yang BH, Wan JL, Jiao J, Wu DQ, Zhang GF, Wang M, Yang HP, Chan H, Li Q.
World J Pediatr; 2022 Feb 04; 18(2):109-119. PubMed ID: 34973118
[Abstract] [Full Text] [Related]
10. Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).
Nagano C, Sako M, Kamei K, Ishikura K, Nakamura H, Nakanishi K, Omori T, Nozu K, Iijima K.
BMC Nephrol; 2019 Aug 02; 20(1):293. PubMed ID: 31375087
[Abstract] [Full Text] [Related]
11. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
Sharma S, Kalra S, Shukla S, Sharma P.
Nephrology (Carlton); 2022 Sep 02; 27(9):758-762. PubMed ID: 35619554
[Abstract] [Full Text] [Related]
12. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
13. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K, Rituximab for Childhood-Onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Pediatr Nephrol; 2017 Nov 10; 32(11):2071-2078. PubMed ID: 28664242
[Abstract] [Full Text] [Related]
14. Feasibility of discontinuing immunosuppression in children with idiopathic nephrotic syndrome.
Sobue Y, Nishi K, Kamei K, Inoki Y, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Ishikura K, Ishiguro A, Ito S.
Pediatr Nephrol; 2024 Jun 10; 39(6):1825-1835. PubMed ID: 38270600
[Abstract] [Full Text] [Related]
15. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
Paediatr Int Child Health; 2018 Nov 10; 38(4):251-260. PubMed ID: 30092157
[Abstract] [Full Text] [Related]
16. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr 10; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
17. Discontinuation of maintenance therapy in frequently relapsing nephrotic syndrome
.
Vogd J, Hackl A, Habbig S, Lechner F, Akarkach A, Weber LT, Ehren R.
Clin Nephrol; 2019 Jan 10; 91(1):25-31. PubMed ID: 30369402
[Abstract] [Full Text] [Related]
18. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children.
J Am Soc Nephrol; 2022 Feb 10; 33(2):401-419. PubMed ID: 34880074
[Abstract] [Full Text] [Related]
19. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
DaSilva I, Huerta A, Quintana L, Redondo B, Iglesias E, Draibe J, Praga M, Ballarín J, Díaz-Encarnación M, Spanish Group for the Study of Glomerular Diseases (GLOSEN).
BioDrugs; 2017 Jun 10; 31(3):239-249. PubMed ID: 28534103
[Abstract] [Full Text] [Related]
20. Incidence of relapse and frequently relapsing/steroid-dependent nephrotic syndrome in Chinese children with steroid-sensitive nephrotic syndrome: A cohort study.
Ying D, Yu N, Lin Z, Chen L, Rong L, Wu J, Jiang M, Jiang X.
Nephrology (Carlton); 2023 Sep 10; 28(9):477-484. PubMed ID: 37254566
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
